Traitement d’entretien par BCG-thérapie des tumeurs de vessie n’infiltrant pas le muscle (TVNIM) : résultats à un an de l’étude multicentrique URO-BCG-4

Low-Dose Versus Standard Dose of Bacillus Calmette-Guerin in the Treatment of Nonmuscle Invasive Bladder Cancer

“…Low-dose BCG maintenance regimens with a reduced number of instillations have been investigated in 2 RCT studies; it was found in the reduced instillation group that treatment was effective with no impact on tumor recurrence or progression. 27,28 …”